Occurrence of Type 1 Diabetes in Graves' Disease Patients Who Are Positive for Antiglutamic Acid Decarboxylase Antibodies: An 8-Year Followup Study

Glutamic acid decarboxylase antibodies (GADAs) are one of the markers of islet cell autoimmunity and are sometimes present before the onset of type 1 diabetes (T1D). GADA can be present in Graves' patients without diabetes; however, the outcome of GADA-positive Graves' patients is not full...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniyama, Matsuo, Kasuga, Akira, Nagayama, Chieko, Ito, Koichi
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021866/
https://www.ncbi.nlm.nih.gov/pubmed/21253552
http://dx.doi.org/10.4061/2011/306487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021866/
https://www.ncbi.nlm.nih.gov/pubmed/21253552
http://dx.doi.org/10.4061/2011/306487

Ejemplares similares